YOU MIGHT BE INTERESTED IN

Amgen - The Biotech Leader - Market Analyses and Outlook, 2008-2023
In 2007, Amgen Inc - the world's largest biotechnology company - achieved total sales of $14.7bn, despite a turbulent year marked by regulatory, pricing and reimbursement issues. Amgen has now firmly established itself as a Top-20 international pharmaceutical company. According to sales data for 2007, Amgen is also ranked as the 11th largest pharmaceutical company worldwide based on total sales value. This is a remarkable achievment for a biotechnology company founded in 1980.
...more details
World Generics Market, 2008-2013
The generics market remains a major growth area in the global healthcare market. That growth has been partly driven by cost-containment in several national healthcare sectors, with governments seeking to promote the use of generic products over higher-priced originator products. The global generic pharmaceuticals market was worth over $100bn in 2007, with market growth noticeably higher that that of the overall pharmaceutical market.
...more details
Top-10 Biotech Companies - Market Outlook, 2008-2023
The biotechnology industry is a major growth area in the global healthcare market, one upon which many companies are placing their hopes. Due to developments in monoclonal antibodies, genomics and proteomics - amongst others - the biotechnology market has experienced great expansion since its emergence during the 1970's.
...more details
Chinese Pharmaceutical Outlook 2008-2023
This brand new report examines the prospects for the growth of pharmaceutical revenues in China. Visiongain predicts that total pharmaceutical revenues in China will increase from approximately $12bn in 2007 to over $30bn in 2013. This is a considerable increase, one that will represent a near tripling of total sales over six years. Strong growth will continue well beyond that period, as this report shows and explains.
...more details
The Japanese Pharmaceutical Market 2008-2023
Last year, the Japanese pharmaceutical market was the second largest in the world, with a value of $58.5bn. However, Japan’s market has experienced growth at a much lower rate than the other major pharmaceutical markets. It is at a key stage in its development. You need to take notice of these changes.
...more details

CONFERENCE

...see all

8th Annual Pricing and Reimbursement Conference

Develop and leverage value-enhancing pricing and reimbursement strategies

11th - 12th June 2009, Philadelphia, USA

Download brochure Products

Background Info
Day 1
Day 2
Partners
Past Papers

Platinum Sponsor

Associate Sponsor

Media Partners

Background Info

“The 8th annual pricing and reimbursement conference addressed its objectives and was both educational and informative.”

President
Institute of Pharmaceutical Management

“The two-days were packed with insightful perspectives on a variety of global issues related to the topic at hand. My fellow-speakers were all thought-leaders from their respective fields, and there wasn’t a moment wasted in an expertly produced and managed conference. In a time when the industry is changing its approach to established markets, shifting to emerging markets, and establishing new modes of value – this conference is a must for globally-minded pricing and market access professionals.”

Vice President, Global Market Access
Insight Strategy Advisors

Details:

"The global pharmaceutical pricing and reimbursement environment is notoriously complex and continuously changing. Pharma companies must implement strategic pricing assessments across global markets and product lifecycle phases in order to develop effective pricing policies." (Source: Business Insights)

Pharmaceutical companies are facing challenges in the present economic climate. An effective pricing strategy is vital in implementation of assessments of cost effectiveness.

Visiongain's 8th Annual Pricing and Reimbursement conference is aimed at providing you with the opportunity to gain an understanding of the healthcare market dynamics and P&R environment and create an effective price policy. This 2 day event will help you achieve competitive advantage in current pricing and reimbursement environment.

Why Attend?
• Share and discuss the key global pricing and reimbursement approaches
• Learn about the current global pharmaceutical market
• Analyse the future pricing trends in US
• Gain insight into the role of health economics in pricing
• Design innovative P&R strategies for biopharmaceuticals
• Stay up-to-date on the latest innovations in pricing and reimbursement
• Seize this opportunity to network with leaders from pharma-biotech, healthcare and regulatory agencies
• Make the most profitable decisions

Key Speakers
• Samir K.Bhattacharyya, Senior Director Global Marketing Home Hemodialysis Therapy, Baxter Healthcare
• Alina Ciobanu, Manager, Health Economics & Patient Access, Astrazeneca
• Dr. Elyce A. Biddle, Senior Research Economist, National Institute for Occupational Safety and Health, U.S Govt.
• Robert Humenick, Head Pricing and Reimbursement, Wyeth Pharmaceuticals
• Dee Woodhull, CIH, CSP Senior Consultant, ORC Worldwide
• Kevin Mayo, Vice President, Bridgehead, Professor, University of the Sciences in Philadelphia
• Dr. Nick Poulios, VP-Pricing & Reimbursement Strategy, Patient Access & Public Policy, Elan Pharmaceuticals
• Todd Evans, Director, Pricewaterhouse Coopers
• Dr. Eugene Mick Kolassa, CEO & Managing Partner, Medical Marketing Economics, LLC
• W. Neil Palmer, Vice President, Pricing & Reimbursement, RTI Health Solutions
• Christian Schuler, Partner, Simon-Kucher & Partners
• Adam L. Sohn, Principal, Pricing & Market Access, IMS Consulting
• William Haddad, CEO, Biogenerics
• George Wyatt, Managing Director, Wyatt Health Management
• Sanjay Bajpai, President, Institute of Pharmaceutical Management
• Cyrus Chowdhury, Management Consultant, Insight Strategy Advisors

Who should attend?
VPs, Directors, Heads and Managers of:
• Pricing and Reimbursement
• Strategic Pricing
• Price Monitoring
• Reimbursement & Market Access
• Research and Development
• Health Economics
• Commercial Pricing
• Economics and Government Affairs
• International Trade and Market Policy
• Parallel Trade
• Business Strategy
• Sales & Marketing
• Corporate Strategy
• Regulatory Affairs
• Outcomes Research
• Contracts
• Legal
• Health Policy Advisors

Day 1

Day 1, Thursday 11th June 2009

09:30 Registration and refreshments

10:00 Opening address from the chair

Dr. Eugene Mick Kolassa
CEO & Managing Partner
Medical Marketing Economics, LLC

10:10 Identifying and overcoming the limitations of current approaches to pharmaceutical pricing
• Why basic economic assumptions and models don’t apply to pharmaceutical markets
• Why many pricing research approaches either ask the wrong questions or lead respondents to the wrong answers
• Why failure to develop true pricing strategies always leaves money on the table
• Why a lack of policies leads to bad pricing
• Why failing to understand value is the number one pricing mistake
• How to bring some pricing discipline and pricing power to your firms

Dr. Eugene Mick Kolassa
CEO & Managing Partner
Medical Marketing Economics, LLC

10:50 How to develop an effective pricing and reimbursement strategy?
• What is an effective strategy? What should the goals be for any strategy?
• The development process and how to maximise value from the outset: the lessons of strategic pricing assessments
• How to stand out from the crowd and develop genuinely innovative P&R strategies

Sanjay Bajpai
President
Institute of Pharmaceutical Management

11:30 Morning refreshments

11:50 Latest innovations in pricing and reimbursement
• Assessing approaches to innovation in the realm of P&R
• The importance of price optimization and individually tailored pricing
• Innovative pricing strategies

Robert Humenick
Head Pricing and Reimbursement
Wyeth Pharmaceuticals

12:30 The future of strategic pricing for pharma

Todd Evans
Director
PricewaterhouseCoopers

13:10 Networking lunch

14:30 Assessment of EU market growth of private healthcare vs public
• Where is the trend line heading? Are traditional levels of public healthcare provision sustainable?
• What is the landscape for private healthcare provision in Europe?
• Increasing private provision of healthcare will involve addressing traditional ideological concerns, making private healthcare more attractive and driving accountability of public healthcare providers

15:10 Comparing the European/US/Canada P&R and HE&OR systems
• What are the similarities between the systems and is there a trend to harmonization?
• What are the crucial differences and which system is most effective?
• What are the implications of developing trends in different P&R systems?

W. Neil Palmer
Vice President, Pricing & Reimbursement
RTI Health Solutions

15:50 Afternoon refreshments

16:10 China: Portfolio, Pricing & Market Access
• Portfolio optimization: Multinational Acclimation
• Pricing: Draconian Dragons
• Market Access: Guanxi Reimbursement

Cyrus Chowdhury
Management Consultant
Insight Strategy Advisors

16:50 Analyzing the future pricing trends in US
• Obamamania, will it effect the development of the P&R system in the US
• Cost-effectiveness in assessing pharma products, will the US adopt such a system in line with spiralling healthcare costs
• Will the US continue to be a lucrative country for headline pricing trends, where next?
Panel members will be drawn from the speakers who take part on day one or day two. If you would like to submit a question to the panel, please email it to: pranita.nangia@visiongainglobal.com

17:30 Closing remarks from the chair

17:35 Networking drinks reception
Take your discussions further and build new relationships in a relaxed and informal setting

Day 2

Day 2, Friday 12th June 2009

09:30 Registration and refreshments

10:00 Opening address from the chair

Dr. Elyce A. Biddle
Senior Research Economist
National Institute for Occupational Safety and Health, U.S Govt.

10:10 How to maximize return on investment?
• All about ROI:
- What metrics are appropriate?
- How do you actually analyse your ROI?
• How do you ensure that your P&R strategy is genuinely and consistently creating value?
• How will broader market and policy changes affect the measurement of ROI?

George Wyatt
Managing Director
Wyatt Health Management

10:50 Presentation to be announced

Alina Ciobanu
Manager, Health Economics & Patient Access
Astrazeneca

11:30 Morning refreshments

11:50 Strategy to implementation: Patients receive treatment choice
• Show how health economics was used to increase reimbursement for therapy access
• Demonstrate the need for collaboration between and within organizations for achieving target results
• Discuss importance of communication strategy and execution plays a significant role in healthcare policy changes

Samir K. Bhattacharyya
Senior Director Global Marketing Home Hemodialysis Therapy
Baxter Healthcare

12:30 Assessment of trends in generic pricing in US
• Pricing methods for generic medicines, what is the state of the art?
• Countering generic medicines pricing; tools and tactics
• Trends in generic pricing specific to the US, in what direction is this going?

William Haddad
CEO
Biogenerics

13:10 Networking lunch

14:10 Key global pricing and reimbursement approaches
• Making a global play: is there a P&R strategy that is effective everywhere?
• Can the development of a globally-focused strategy actually contribute to P&R harmonisation?
• The importance of the product and evolving product trends to the feasibility of a global strategy

Adam L. Sohn
Principal, Pricing & Market Access
IMS Consulting

14:40 Measuring the value of reducing the risk of occupational injury or illness on the firm
• Reducing or eliminating hazards to protect employees can reduce costs and increase production
• Value is found by reducing costs and increasing production, as well as accomplishing other business objectives
• The specific financial benefits of reducing risk may be found throughout a business process, and can be substantial
• Risk reduction may enable the achievement of non-financial benefits that have an indirect relationship to cost and production

Dr. Elyce A. Biddle
Senior Research Economist
National Institute for Occupational Safety and Health, U.S Govt.

Dee Woodhull
CIH, CSP Senior Consultant
ORC Worldwide

15:20 Pricing & reimbursement and market access strategies for new oncology products
• Current global pricing & reimbursement landscape for new oncologic agents
• Future trends and challenges in P&R for oncology products
• Lifecycle P&R issues associated with oncology drugs
• Developing successful international P&R strategies for oncologic agents
• Risk-sharing for pharmaceuticals in the US and EU

Christian Schuler
Partner
Simon-Kucher & Partners

16:00 Afternoon refreshments

16:20 The ultimate patient access: keeping the patient off the illness curve

Dr. Nick Poulios
VP-Pricing & Reimbursement Strategy, Patient Access & Public Policy
Elan Pharmaceuticals

17:00 Health Economics and its contribution to effective and sustainable P&R strategies
• The ever more important contribution of Health economics and Outcomes research as a key component of P&R strategies
• Taking the lead on health economics to get ahead of restrictive regulation and regional idiosyncrasies
• Expected evolution or maybe the revolution offered by health economics and outcomes research, a critical assessment

Kevin W. Mayo
Vice President
Bridgehead
Professor for Mayes College of HealthCare Business and Policy (University of the Sciences in Philadelphia)

17:30 Chair’s closing remarks

17:40 End of conference

Partners

Platinum Sponsor:

IMS Health
Operating in more than 100 countries, IMS Health is the world’s leading provider of market intelligence to the pharmaceutical and healthcare industries. With $2.2 billion in 2007 revenue and more than 50 years of industry experience, IMS offers leading-edge market intelligence products and services that are integral to clients’ day-to-day operations, including portfolio optimization capabilities; launch and brand management solutions; sales force effectiveness innovations; managed care and consumer health offerings; and consulting and services solutions that improve ROI and the delivery of quality healthcare worldwide. For further information please visit: www.imshealth.com

Associate Sponsor:

PriceSpective
PriceSpective is a management consulting firm specializing in innovative strategies to identify, capture, and communicate value for products, portfolios, and companies in the biopharmaceutical arena. We are uniquely positioned to deliver expert guidance in integrated global pricing and reimbursement (P&R) strategy due to our depth of experience with pricing and market access dynamics and the active engagement of our senior leadership. A flat operational model ensures that senior personnel are deeply involved in all aspects of project delivery to guide and ensure actionable insights. PriceSpective has experience in over 30 markets across North America, Europe, Asia, Latin America, and the Pacific region. Offices in London, Los Angeles, and Philadelphia provide the geographic scope to support our global capabilities. These locations are staffed by a team of experienced pricing professionals a mix of pharmaceutical industry, payer, medical, and consulting backgrounds. For further information please visit: www.pricespective.com

Media Partners:

PharmiWeb.com
PharmiWeb.com is the leading industry-sponsored portal for the pharmaceutical sector. Supported by most of the leading pharmaceutical corporations, PharmiWeb.com provides dynamic real-time news, features, events listings and international jobs to industry professionals across Europe and the US. For further information please email: corporate@pharmiweb.com

BIOTECHNOLOGY EUROPE
BIOTECHNOLOGY EUROPE is owned by BIOTECHNOLOGY WORLD. It is based and located in Warsaw, Poland. Biotechnology World was founded in 2007 to provide the world’s biotech and pharma information and market to make it universally accessible and useful for scientific and business processes. Its first step to fulfilling that mission was building the BIOTECHNOLOGY EUROPE platform that will allow a quick spread of information in different channels. BIOTECHNOLOGY EUROPE offers companies completed internet public relations, publication and marketing solutions. One of the main goals of BIOTECHNOLOGY EUROPE is to integrate the Biotech and Pharma Sector in Europe to global biotechnology, pharmaceutical and life science activities. For further information please visit www.biotechnology-europe.com

Future Pharmaceuticals
Future Pharmaceuticals has forged powerful relationships with key industry leaders to provide a platform for successful brand recognition, and for senior decision-makers to have the means to procure and plan implementation strategies based on the topics covered. Positioned to be an authoritative resource within top pharma companies as well as small, specialty, and biotech, Future Pharmaceuticals magazine is geared to create a deep penetration into a highly targeted and responsive audience, bridging the gap between the industries' top issues and the solutions top-tier vendors can provide. For further information, please visit www.futurepharmaus.com

InPharm
InPharm is the online platform for exclusive pharmaceutical news, comment, contracts, services, jobs and events and is home to InPharmjobs.com, Pharmafile and Pharmafocus. For further information please visit: www.In-Pharm.com

Pharma and Healthcare Insight
Pharma and Healthcare Insight provides subscribers with analysis, forecasts and company profiles on a country-by-country basis, covering the key trends impacting on global pharma and healthcare markets. The service includes online access to the very latest analysis and data, a searchable archive, and PDF access to the monthly regional Insight reports. Published by Business Monitor International, the global market specialists, Pharma and Healthcare Insight is broken down into five regional services: Asia, Western Europe, Emerging Europe, the Middle East & Africa and the Americas. For further information please visit: www.pharmaceuticalsinsight.com

Bio Spectrum
Bio Spectrum is India’s first monthly comprehensive Biotech business magazine covering the entire happenings in the exciting areas of BioPharma, BioAgriculture, BioInformatics, BioIndustrial, BioSuppliers and BioServices. BioSpectrum has columns by India’s top policy makers, biotechnology professionals, scientists and NGOs and show cases the emerging Indian entrepreneurship in biotechnology. BioSpectrum reaches over 40,000 key decision makers in the Pharma and Biotech industry. Readers of BioSpectrum are from among the key policy makers, Consultants, Fund managers, Key executives and the influencers in pharmaceutical / agricultural companies, research labs / educational institutes, the clinical research, clinical trials and contract manufacturing organizations and the industrial sectors besides other auxiliary sectors. BioSpectrum is already the "Voice of Indian BT industry". BioSpectrum has emerged as the most preferred forum to engage the Indian biotech community reaching out to 1,38,000 readers world wide. For further information please visit: http://biospectrumindia.ciol.com

Applied Management Consultants Ltd.
Applied Management Consultants Ltd. is an employee-owned and managed Canadian health care consulting firm practicing in the areas of health policy, strategic planning, drug insurance programs, health economics and program evaluation. Current services include:
• End-to-end consulting and analytics required for securing public and private sector reimbursement
• Market access planning;
• Health and pharmacoeconomic analyses;
• Policy analysis and development;
• Health information; and
• Program evaluation and operations analysis
We sell extensive datasets and models on coverage and payer dynamics in the Canadian marketplace. Our consultants, analysts and associates are recognized experts in reimbursement and payer analytics. For further information please visit: www.appliedmanagement.ca

Enquiries

If you would like more information on the range of sponsorship or exhibition possibilities for this conference, please contact:
Patricia Gallegos, +44 (0)20 7549 9952
patricia.gallegos@visiongainglobal.com

Past Papers

Speaker presentations are free to delegates. If you are unable to attend the event, the presentations are published two weeks after the event and are available to purchase.

Buy Now